These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3179478)

  • 1. Perfluorochemical emulsions with fluorinated surfactants and anticancer drugs.
    Fung BM; O'Rear EA; Afzal J; Frech CB; Mamrosh DL; Gangoda M
    Biomater Artif Cells Artif Organs; 1988; 16(1-3):439-40. PubMed ID: 3179478
    [No Abstract]   [Full Text] [Related]  

  • 2. Design, synthesis and evaluation of fluorocarbons and surfactants for in vivo applications. New perfluoroalkylated polyhydroxylated surfactants.
    Riess JG; Arlen C; Greiner J; Le Blanc M; Manfredi A; Pace S; Varescon C; Zarif L
    Biomater Artif Cells Artif Organs; 1988; 16(1-3):421-30. PubMed ID: 3052646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phospholipid vesiculated fluorocarbons--promising trend in blood substitutes.
    Gross U; Rüdiger S; Reichelt H; Draffehn J
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):831-3. PubMed ID: 1391517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability and stabilization of fluorocarbon emulsions destined for injection.
    Riess JG; Postel M
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):819-30. PubMed ID: 1391516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel compositions of emulsified perfluorochemicals for biological uses.
    Sharma SK; Lowe KC; Davis SS
    Biomater Artif Cells Artif Organs; 1988; 16(1-3):447-50. PubMed ID: 3179481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of lipid emulsifiers on the properties of organoperfluorine emulsions].
    Oksinoĭd OE; Romanova MZh; Afonin NI
    Vestn Akad Med Nauk SSSR; 1990; (8):37-41. PubMed ID: 2275276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorinated materials for in vivo oxygen transport (blood substitutes), diagnosis and drug delivery.
    Riess JG; Krafft MP
    Biomaterials; 1998 Aug; 19(16):1529-39. PubMed ID: 9794531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The safety and efficacy of perfluorochemical emulsions as blood substitutes.
    Sloviter HA
    Biomater Artif Cells Artif Organs; 1988; 16(1-3):459-61. PubMed ID: 3052647
    [No Abstract]   [Full Text] [Related]  

  • 9. Interfacial properties as stability predictors of lecithin-stabilized perfluorocarbon emulsions.
    Yoon JK; Burgess DJ
    Pharm Dev Technol; 1996 Dec; 1(4):333-41. PubMed ID: 9552317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surfactants and perfluorochemical emulsions for use in blood replacement preparations.
    Geyer RP
    Int Anesthesiol Clin; 1985; 23(1):25-36. PubMed ID: 3980106
    [No Abstract]   [Full Text] [Related]  

  • 11. Intravascular behavior of a perfluorochemical emulsion.
    Tsuda Y; Yamanouchi K; Okamoto H; Yokoyama K; Heldebrant C
    J Pharmacobiodyn; 1990 Mar; 13(3):165-71. PubMed ID: 2374085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Non-ionogenic surface-active agents as a component of oxygen carrying fluorocarbon blood substitutes].
    Afonin NI; Rybolovleva IuR; Putiatina TK; Aprosin IuD; Doronina NN
    Probl Gematol Pereliv Krovi; 1982 Oct; 27(10):12-4. PubMed ID: 7178045
    [No Abstract]   [Full Text] [Related]  

  • 13. Perfluoroalklylated phospholipids as surfactants and co-surfactants forinjectable fluorocarbon emulsions.
    Santaella C; Vierling P; Riess JG
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):835-7. PubMed ID: 1391518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Artificial blood emulsifiers.
    Schmolka IR
    Fed Proc; 1975 May; 34(6):1449-53. PubMed ID: 1126441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of fluorocarbon emulsions in cancer radiotherapy.
    Guichard M
    Radiother Oncol; 1991; 20 Suppl 1():59-64. PubMed ID: 2020771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorocarbons and fluorinated amphiphiles in drug delivery and biomedical research.
    Krafft MP
    Adv Drug Deliv Rev; 2001 Apr; 47(2-3):209-28. PubMed ID: 11311993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fluorocarbons as possible oxygen-carrying blood substitutes].
    Afonin NI; Doronina NN
    Probl Gematol Pereliv Krovi; 1981 Jan; 26(1):41-5. PubMed ID: 7220520
    [No Abstract]   [Full Text] [Related]  

  • 18. Medical oxygen transport using perfluorochemicals.
    Kaufman RJ
    Biotechnology; 1991; 19():127-62. PubMed ID: 1786469
    [No Abstract]   [Full Text] [Related]  

  • 19. [Problem of creating "artificial blood" based on organofluorine compounds].
    Iarochkin VS; Koziner VB
    Patol Fiziol Eksp Ter; 1981; (3):78-87. PubMed ID: 6456440
    [No Abstract]   [Full Text] [Related]  

  • 20. [Mechanism of the enhanced stability of emulsions of perfluoro-organic compounds in the circulatory bed].
    Pavlova-Verevkina OB; Aprosin IuD; Afonin NI
    Gematol Transfuziol; 1987 May; 32(5):50-2. PubMed ID: 3609686
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.